SK287554B6 - Bicyklické heteroaromatické zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Bicyklické heteroaromatické zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK287554B6
SK287554B6 SK331-2003A SK3312003A SK287554B6 SK 287554 B6 SK287554 B6 SK 287554B6 SK 3312003 A SK3312003 A SK 3312003A SK 287554 B6 SK287554 B6 SK 287554B6
Authority
SK
Slovakia
Prior art keywords
pyrimidine
methylthio
amino
thieno
tert
Prior art date
Application number
SK331-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK3312003A3 (en
Inventor
Cornelis Marius Timmers
Willem Frederik Johan Karstens
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of SK3312003A3 publication Critical patent/SK3312003A3/sk
Publication of SK287554B6 publication Critical patent/SK287554B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK331-2003A 2000-09-22 2001-09-17 Bicyklické heteroaromatické zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie SK287554B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22
PCT/EP2001/010743 WO2002024703A1 (fr) 2000-09-22 2001-09-17 Composés hétéroaromatique bicyclique

Publications (2)

Publication Number Publication Date
SK3312003A3 SK3312003A3 (en) 2003-08-05
SK287554B6 true SK287554B6 (sk) 2011-01-04

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
SK331-2003A SK287554B6 (sk) 2000-09-22 2001-09-17 Bicyklické heteroaromatické zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (32)

Country Link
US (2) US7229990B2 (fr)
EP (2) EP1322651B1 (fr)
JP (1) JP4977940B2 (fr)
KR (1) KR100860040B1 (fr)
CN (1) CN1247594C (fr)
AR (1) AR030784A1 (fr)
AT (1) ATE384726T1 (fr)
AU (2) AU2002213929B2 (fr)
BR (1) BR0113987A (fr)
CA (1) CA2422054C (fr)
CY (1) CY1107308T1 (fr)
CZ (1) CZ297136B6 (fr)
DE (1) DE60132607T2 (fr)
DK (1) DK1322651T3 (fr)
EC (1) ECSP034523A (fr)
ES (1) ES2299524T3 (fr)
HK (1) HK1054942A1 (fr)
HR (1) HRP20030220B1 (fr)
HU (1) HU229422B1 (fr)
IL (2) IL154624A0 (fr)
IS (1) IS2531B (fr)
MX (1) MXPA03002478A (fr)
NO (1) NO328683B1 (fr)
NZ (1) NZ524444A (fr)
PE (1) PE20020537A1 (fr)
PL (1) PL207755B1 (fr)
PT (1) PT1322651E (fr)
RU (1) RU2271360C2 (fr)
SK (1) SK287554B6 (fr)
TW (1) TWI290143B (fr)
WO (1) WO2002024703A1 (fr)
ZA (1) ZA200301588B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2422054C (fr) * 2000-09-22 2011-01-11 Akzo Nobel Nv Composes heteroaromatique bicyclique
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
WO2006124490A2 (fr) * 2005-05-17 2006-11-23 Schering Corporation Heterocycles utilises comme agonistes du recepteur de l'acide nicotinique dans le traitement de la dyslipidemie
JP2009537551A (ja) * 2006-05-17 2009-10-29 アメリカ合衆国 ホルモン受容体を調節するためのピリミジン低分子量リガンド
EP2280969A1 (fr) 2008-04-29 2011-02-09 F. Hoffmann-La Roche AG Pyrimidinyle pyridones inhibiteurs de jnk
CA2741030A1 (fr) 2008-10-20 2010-04-29 Marvin C. Gershengorn Agonistes de faible poids moleculaire du recepteur de l'hormone stimulatrice de la thyroide (tshr)
CA2789818A1 (fr) 2010-04-08 2011-10-13 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Agonistes inverses et antagonistes neutres pour recepteur du tsh
EP3392252B1 (fr) 2011-08-23 2023-10-04 Libertas Bio, Inc. Composés de pyrimido-pyridazinone et leurs procédés d'utilisation
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL181895B1 (pl) * 1994-06-16 2001-10-31 Pfizer Nowe pirazolo-i pirolopirydyny _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ PL PL PL PL
EP0920319A4 (fr) * 1996-05-20 2002-05-02 Merck & Co Inc Antagonistes de la gonadoliberine
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
CA2422054C (fr) * 2000-09-22 2011-01-11 Akzo Nobel Nv Composes heteroaromatique bicyclique

Also Published As

Publication number Publication date
AU2002213929B2 (en) 2006-04-13
IL154624A0 (en) 2003-09-17
SK3312003A3 (en) 2003-08-05
PL360675A1 (en) 2004-09-20
RU2271360C2 (ru) 2006-03-10
EP1886999A2 (fr) 2008-02-13
HU229422B1 (hu) 2013-12-30
KR20030040483A (ko) 2003-05-22
BR0113987A (pt) 2003-08-12
US20030225113A1 (en) 2003-12-04
US7618963B2 (en) 2009-11-17
PL207755B1 (pl) 2011-01-31
DK1322651T3 (da) 2008-06-02
NO328683B1 (no) 2010-04-26
HUP0302648A2 (hu) 2003-11-28
NZ524444A (en) 2004-03-26
JP4977940B2 (ja) 2012-07-18
AU1392902A (en) 2002-04-02
CA2422054C (fr) 2011-01-11
US20070197527A1 (en) 2007-08-23
DE60132607D1 (de) 2008-03-13
HUP0302648A3 (en) 2004-11-29
IS6732A (is) 2003-02-28
EP1886999A8 (fr) 2010-08-04
CN1462273A (zh) 2003-12-17
HRP20030220B1 (en) 2011-10-31
HRP20030220A2 (en) 2003-06-30
ATE384726T1 (de) 2008-02-15
HK1054942A1 (en) 2003-12-19
PE20020537A1 (es) 2002-06-20
US7229990B2 (en) 2007-06-12
KR100860040B1 (ko) 2008-09-25
ECSP034523A (es) 2003-04-25
EP1886999A3 (fr) 2008-03-12
NO20031314L (no) 2003-03-21
ZA200301588B (en) 2004-06-22
MXPA03002478A (es) 2004-05-05
DE60132607T2 (de) 2009-01-29
WO2002024703A1 (fr) 2002-03-28
CZ2003828A3 (cs) 2003-08-13
AR030784A1 (es) 2003-09-03
IL154624A (en) 2009-09-01
TWI290143B (en) 2007-11-21
PT1322651E (pt) 2008-02-28
EP1322651A1 (fr) 2003-07-02
CA2422054A1 (fr) 2002-03-28
NO20031314D0 (no) 2003-03-21
EP1322651B1 (fr) 2008-01-23
CY1107308T1 (el) 2012-11-21
JP2004509896A (ja) 2004-04-02
CZ297136B6 (cs) 2006-09-13
IS2531B (is) 2009-07-15
ES2299524T3 (es) 2008-06-01
CN1247594C (zh) 2006-03-29

Similar Documents

Publication Publication Date Title
US6569863B1 (en) Bicyclic heteroamatic compounds useful as LH agonists
US7618963B2 (en) Bicyclic heteroaromatic compounds
EP1427733B1 (fr) Thieno[2,3-d]pyrimidines a activité agoniste lh et fsh combinée
AU2002337035A1 (en) Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
EP1427734B1 (fr) THIENO[2,3-d]PYRIMIDINES GLYCINO-SUBSTITUEES A ACTIVITE AGONISTE COMBINEE LH ET FSH

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: MSD OSS B.V., OSS, NL

Free format text: FORMER OWNER: N.V. ORGANON, OSS, NL

Effective date: 20120326

PC4A Assignment and transfer of rights

Owner name: MERCK SHARP & DOHME B.V., BN HAARLEM, NL

Free format text: FORMER OWNER: ORGANON BIOSCIENCES NEDERLAND B.V., AB OSS, NL

Effective date: 20130729

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V., AB OSS, NL

Free format text: FORMER OWNER: MSD OSS B.V., OSS, NL

Effective date: 20130729

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20150917